Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
30.9M
-
Number of holders
-
477
-
Total 13F shares, excl. options
-
23.8M
-
Shares change
-
-119K
-
Total reported value, excl. options
-
$5.76B
-
Value change
-
-$27.5M
-
Put/Call ratio
-
0.79
-
Number of buys
-
215
-
Number of sells
-
-226
-
Price
-
$242.13
Significant Holders of Medpace Holdings, Inc. - Common Stock (MEDP) as of Q3 2023
540 filings reported holding MEDP - Medpace Holdings, Inc. - Common Stock as of Q3 2023.
Medpace Holdings, Inc. - Common Stock (MEDP) has 477 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23.8M shares
of 30.9M outstanding shares and own 77.1% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (2.41M shares), BlackRock Inc. (2.38M shares), WASATCH ADVISORS LP (1.27M shares), STATE STREET CORP (646K shares), RIVERBRIDGE PARTNERS LLC (641K shares), FULLER & THALER ASSET MANAGEMENT, INC. (638K shares), Invesco Ltd. (612K shares), Boston Trust Walden Corp (540K shares), GEODE CAPITAL MANAGEMENT, LLC (486K shares), and DIMENSIONAL FUND ADVISORS LP (467K shares).
This table shows the top 477 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.